{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:01:06Z","timestamp":1792731666403,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015582","name":"Ovarian Cancer Academy","doi-asserted-by":"publisher","award":["OC093443"],"award-info":[{"award-number":["OC093443"]}],"id":[{"id":"10.13039\/100015582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001282","name":"Ovarian Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12 HD00849"],"award-info":[{"award-number":["K12 HD00849"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ajog.2013.04.019","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T10:35:38Z","timestamp":1365590138000},"page":"409-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":251,"title":["The role of the fallopian tube in the origin of ovarian cancer"],"prefix":"10.1016","volume":"209","author":[{"given":"Britt K.","family":"Erickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Conner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles N.","family":"Landen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2013.04.019_bib1","first-page":"143","article-title":"Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society","volume":"56","author":"Winawer","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2013.04.019_bib2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1095\/biolreprod.105.043133","article-title":"Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone","volume":"73","author":"Pudney","year":"2005","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2013.04.019_bib3","first-page":"1707","article-title":"Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage","volume":"58","author":"Jiang","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2013.04.019_bib4","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2013.04.019_bib5","first-page":"212","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2013.04.019_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","article-title":"Morphological subtypes of\u00a0ovarian carcinoma: a review with emphasis on\u00a0new developments and pathogenesis","volume":"43","author":"McCluggage","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.ajog.2013.04.019_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in\u00a0high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib8","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and\u00a0molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer","volume":"26","author":"Landen","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2013.04.019_bib10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.pas.0000166367.68459.7d","article-title":"An\u00a0immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2\/neu, and C-KIT in high-grade neoplasms","volume":"29","author":"O'Neill","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004347-200301000-00009","article-title":"Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor)","volume":"22","author":"Singer","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.0.CO;2-W","article-title":"E-cadherin expression in human epithelial ovarian cancer and normal ovary","volume":"74","author":"Sundfeldt","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2013.04.019_bib14","first-page":"361","article-title":"Peritoneal mesothelium and ovarian surface cells\u2013shared characteristics","volume":"3","author":"Blaustein","year":"1984","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib15","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","article-title":"Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon","volume":"11","author":"Marquez","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajog.2013.04.019_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2013a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2013.04.019_bib17","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2013.04.019_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(79)91435-1","article-title":"\"Incessant ovulation\" and ovarian cancer","volume":"2","author":"Casagrande","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2013.04.019_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1055-9965.EPI-07-0089","article-title":"Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study","volume":"16","author":"Soegaard","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2013.04.019_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ije\/22.2.192","article-title":"Lactation and the risk of epithelial ovarian cancer: the WHO collaborative study of neoplasia and steroid contraceptives","volume":"22","author":"Rosenblatt","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajog.2013.04.019_bib21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198210213071703","article-title":"Factors affecting the association of oral contraceptives and ovarian cancer","volume":"307","author":"Cramer","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2013.04.019_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ije\/18.3.538","article-title":"Epithelial ovarian cancer and combined oral contraceptives: the WHO collaborative study of\u00a0neoplasia and steroid contraceptives","volume":"18","year":"1989","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajog.2013.04.019_bib23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0029-7844(96)00226-8","article-title":"Epithelial ovarian cancer risk among women with polycystic ovary syndrome","volume":"88","author":"Schildkraut","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.019_bib24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/oxfordjournals.aje.a117055","article-title":"A\u00a0case-control study of oral contraceptive use and invasive epithelial ovarian cancer","volume":"139","author":"Rosenberg","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2013.04.019_bib25","first-page":"717","article-title":"Determinants of ovarian cancer risk, II: inferences regarding pathogenesis","volume":"71","author":"Cramer","year":"1983","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2013.04.019_bib26","first-page":"1531","article-title":"Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women","volume":"12","author":"Arslan","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2013.04.019_bib27","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.1995.03530240036037","article-title":"Serum gonadotropins and steroid hormones and the development of ovarian cancer","volume":"274","author":"Helzlsouer","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2013.04.019_bib28","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2013.04.019_bib29","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2013.04.019_bib30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/PAS.0b013e31823732a9","article-title":"Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon","volume":"36","author":"Boyd","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0301-2115(03)00047-2","article-title":"Prevalence of endometriosis in malignant epithelial ovary tumors","volume":"109","author":"Oral","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2013.04.019_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib33","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2013.04.019_bib34","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.AOG.0000187892.78392.3f","article-title":"BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?","volume":"106","author":"Cass","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.019_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.04.019_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":"BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2013.04.019_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A\u00a0candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"13","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc1783","article-title":"Locus-specific mutation databases: pitfalls and good practice based on the p53 experience","volume":"6","author":"Soussi","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajog.2013.04.019_bib41","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2013evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib43","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e318229449f","article-title":"Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis","volume":"35","author":"Kurman","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib44","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of\u00a0screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2013.04.019_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2012.43.6691","article-title":"Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule","volume":"31","author":"Drescher","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2013.04.019_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK collaborative trial of ovarian cancer screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2013.04.019_bib47","doi-asserted-by":"crossref","first-page":"e1000114","DOI":"10.1371\/journal.pmed.1000114","article-title":"The preclinical natural history of serous ovarian cancer: defining the target for early detection","volume":"6","author":"Brown","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2013.04.019_bib48","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PGP.0b013e31824cbeb4","article-title":"Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Kuhn","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib49","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1097\/PAS.0b013e31825ec07a","article-title":"The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma","volume":"36","author":"Kuhn","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2013.04.019_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/GRF.0b013e31824b1725","article-title":"The oviduct and ovarian cancer: causality, clinical implications, and \u201ctargeted prevention.\u201d","volume":"55","author":"Crum","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.019_bib51","doi-asserted-by":"crossref","first-page":"858647","DOI":"10.5402\/2011\/858647","article-title":"Carcinomas of distal fallopian tube and their association with tubal intraepithelial carcinoma: do they share a common \"precursor\" lesion? loss of\u00a0heterozygosity and immunohistochemical analysis using PAX 2, WT-1, and P53 markers","volume":"2011","author":"Chivukula","year":"2011","journal-title":"ISRN Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.019_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2013.04.019_bib53","doi-asserted-by":"crossref","first-page":"34e1","DOI":"10.1016\/j.ajog.2007.05.039","article-title":"Inpatient hysterectomy surveillance in the United States, 2000-2004","volume":"198","author":"Whiteman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.019_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1258\/mi.2008.008016","article-title":"Prophylactic oophorectomy in premenopausal women and long-term health","volume":"14","author":"Shuster","year":"2008","journal-title":"Menopause Int"},{"key":"10.1016\/j.ajog.2013.04.019_bib55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.019_bib56","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/humrep\/der274","article-title":"The post-reproductive fallopian tube: better removed?","volume":"26","author":"Dietl","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2013.04.019_bib57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.04.019_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2013.04.019_bib59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1600-0412.2011.01114.x","article-title":"Underlying mechanisms of ovarian cancer risk reduction after tubal ligation","volume":"90","author":"Cibula","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2013.04.019_bib60","doi-asserted-by":"crossref","first-page":"167ra4","DOI":"10.1126\/scitranslmed.3004952","article-title":"Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers","volume":"5","author":"Kinde","year":"2013","journal-title":"Sci Transl Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813003827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813003827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:32:25Z","timestamp":1762079545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937813003827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0002937813003827"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2013.04.019","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the fallopian tube in the origin of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2013.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}